【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets/Categories Covered 12
3.1 Wound Care Management 12
3.1.1 Advanced Wound Management 12
3.1.2 Traditional Wound Management 12
3.1.3 Wound Closure Devices 12
4 Company Snapshot 13
4.1 Key Facts 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13
4.5 Business Overview 14
4.6 Major Products and Services 15
4.6.1 Overview 15
5 History 16
6 SWOT Analysis 21
6.1 Overview 21
6.2 Derma Sciences, Inc. Strengths 21
6.2.1 Broad Product Portfolio 21
6.2.2 Strong Manufacturing Capabilities 22
6.2.3 Strong Liquidity Position 22
6.3 Derma Sciences, Inc. Weaknesses 23
6.3.1 Weak Bottom Line 23
6.3.2 Over-dependence on the US Market 23
6.4 Derma Sciences, Inc. Opportunities 23
6.4.1 Acquisition of MedEfficiency 23
6.4.2 Aging Population 23
6.4.3 Promising Pipeline Products 24
6.5 Derma Sciences, Inc. Threats 24
6.5.1 Stringent Government Regulations 24
6.5.2 Competitive Landscape 24
6.5.3 Rapid Technological Changes 24
7 Competitors 25
8 Competitive Landscape 26
8.1 Wound Care Management (Advanced Wound Management), Global, Market Share (%), 2011 26
8.2 Derma Sciences, Inc., Wound Care Management (Advanced Wound Management), by Region, Market Share (2011) 28
8.3 Derma Sciences, Inc., Wound Care Management (Advanced Wound Management), by Country, Market Share (2011) 29
8.4 Wound Care Management (Traditional Wound Management), Global, Market Share (%), 2011 30
8.5 Derma Sciences, Inc., Wound Care Management (Traditional Wound Management), by Region, Market Share (2011) 32
8.6 Derma Sciences, Inc., Wound Care Management (Traditional Wound Management), by Country, Market Share (2011) 33
8.7 Wound Care Management (Wound Closure Devices), Global, Market Share (%), 2011 34
8.8 Derma Sciences, Inc., Wound Care Management (Wound Closure Devices), by Region, Market Share (2011) 36
8.9 Derma Sciences, Inc., Wound Care Management (Wound Closure Devices), by Country, Market Share (2011) 36
8.10 Derma Sciences, Inc., Wound Care Management, Global, Category Revenue Share (2011) 37
8.11 Derma Sciences, Inc., Europe, Category Revenue Share (2011) 39
8.11.1 Derma Sciences, Inc., United Kingdom, Category Revenue Share (2011) 41
8.12 Derma Sciences, Inc., North America, Category Revenue Share (2011) 43
8.12.1 Derma Sciences, Inc., Canada, Category Revenue Share (2011) 45
8.12.2 Derma Sciences, Inc., United States, Category Revenue Share (2011) 47
8.13 Derma Sciences, Inc., South and Central America, Category Revenue Share (2011) 49
8.13.1 Derma Sciences, Inc., Brazil, Category Revenue Share (2011) 51
8.13.2 Derma Sciences, Inc., Other South and Central America, Category Revenue Share (2011) 51
9 Key Employees 53
10 Key Employee Biographies 54
11 Company Statement 55
12 Locations And Subsidiaries 60
12.1 Head Office 60
12.2 Other Locations & Subsidiaries 60
13 Financial Deals Landscape 61
13.1 Derma Sciences, Inc., Deals Volume Summary, 2007 to 2012 61
14 Derma Sciences, Inc. Detailed Deal Summary 63
14.1 Partnerships 63
14.1.1 Derma Sciences Enters Into Licensing Agreement With Quick-Med Technologies For NIMBUS 63
14.1.2 Comvita New Zealand Enters Into An Agreement With Derma Sciences 65
14.1.3 Derma Sciences Enters Into Licensing Agreement With C-Boot 66
14.1.4 Derma Sciences Signs Licensing Agreement With Quick-Med Technologies 67
14.1.5 Derma Sciences Enters Into Distribution Agreement With Medline Industries 68
14.1.6 Derma Sciences Signs An Agreement With MedEfficiency 69
14.1.7 Derma Sciences Signs An Agreement With Novation 70
14.2 Equity Offering 71
14.2.1 Derma Sciences Completes Public Offering Of Shares For $36 Million 71
14.2.2 Derma Sciences Completes Private Placement Of Common Stock For $20 Million 73
14.2.3 Derma Sciences Completes Private Placement For $29 Million 75
14.2.4 Derma Sciences Completes Public Offering Of Common Stock For $5.6 Million 77
14.2.5 Derma Sciences Completes Private Placement Of $6.1 Million 79
14.2.6 Derma Sciences Completes Private Placement Of $6 Million 80
14.3 Acquisition 82
14.3.1 Derma Sciences Acquires MedEfficiency, Wound Care Management Company, For $14.5 Million 82
15 Recent Developments 84
15.1 Strategy And Business Planning 84
15.1.1 May 12, 2010: Derma Sciences Establishes New International Subsidiary In UK 84
15.2 Financial Announcements 84
15.2.1 Nov 12, 2012: Derma Sciences Reports Revenue Of $19.6m In Q3 2012 84
15.2.2 Aug 13, 2012: Derma Sciences Reports Revenue Of $17.6m In Q2 2012 85
15.2.3 May 15, 2012: Derma Sciences Reports Net Sales Of $15.3m In Q1 2012 85
15.2.4 Mar 29, 2012: Derma Sciences Reports Net Sales Of $16.5m In Q4 2011 86
15.2.5 Nov 11, 2011: Derma Sciences Reports Net Sales Of $15.8m In Q3 2011 86
15.2.6 Aug 16, 2011: Derma Sciences Reports Net Sales Of $15.9m In Q2 2011 87
15.2.7 May 11, 2011: Derma Sciences Reports Net Sales Of $14.4m In Q1 2011 88
15.2.8 Mar 30, 2011: Derma Sciences Reports Net Sales Of $56.5m In 2010 89
15.2.9 Nov 12, 2010: Derma Sciences Reports Net Sales Of $15.1 Million For Q3 2010 90
15.2.10 Aug 13, 2010: Derma Sciences Reports Net Sales Of $13.23 Million In Q2 2010 91
15.2.11 May 13, 2010: Derma Sciences Reports Net Sales Of $12.8 Million In Q1 2010 92
15.2.12 Apr 01, 2010: Derma Sciences Reports Net Sales Of $48.5 Million In 2009 93
15.2.13 Nov 16, 2009: Derma Sciences Reports Net Sales Of $12.9 Million In Q3 2009 94
15.2.14 Aug 17, 2009: Derma Sciences Reports Net Sales Of $11.6 Million In Q2 2009 95
15.2.15 May 18, 2009: Derma Sciences Posts Net Sales Of $10.4 Million In Q1 2009 96
15.2.16 Apr 01, 2009: Derma Sciences Posts Net Loss Of $3.96 Million For 2008 97
15.2.17 Nov 17, 2008: Derma Sciences Reports 3Q 2008 Results 98
15.2.18 Aug 14, 2008: Derma Sciences Reports 2Q 2008 Results 99
15.2.19 May 15, 2008: Derma Sciences Reports Q1 2008 Results 100
15.2.20 Apr 01, 2008: Derma Sciences Reports Q4 2007 Results 101
15.2.21 Mar 24, 2008: Derma Sciences To Declare Q4 2007 Results 101
15.2.22 Nov 13, 2007: Derma Sciences Reports Q3 2007 Results 102
15.2.23 May 16, 2007: Derma Sciences Declares Q1 2007 Results 103
15.2.24 Apr 02, 2007: Derma Sciences Reports Q4 2006 Results 103
15.2.25 Nov 14, 2006: Derma Sciences Reports Q3 2006 Results 104
15.2.26 Aug 15, 2006: Derma Sciences Reports Q2 2006 Results 105
15.3 Research And Development 106
15.3.1 Apr 18, 2011: Derma Sciences MEDIHONEY And XTRASORB Posters And Expert Presentations Featured At SAWC 2011 106
15.4 Corporate Communications 107
15.4.1 May 12, 2010: Derma Sciences Appoints Maeve Kelly As Managing Director, EMEA 107
15.4.2 Feb 10, 2010: Derma Sciences To List Its Common Stock On NASDAQ 107
15.4.3 Feb 09, 2010: Derma Sciences To List Its Common Stock On NASDAQ 107
15.4.4 May 05, 2009: Derma Sciences Reports Voluntary Delisting From Defunct Boston Stock Exchange 108
15.4.5 Jan 18, 2008: Derma Sciences Increases Direct Sales Force For Advanced Wound Care 108
15.5 Government and Public Interest 109
15.5.1 Nov 04, 2011: Derma Sciences To Present At Lazard Capital Markets 8th Annual Healthcare Conference 109
15.5.2 Sep 26, 2011: Derma Sciences To Present At Jefferies 2011 Global Healthcare Conference 109
15.5.3 Nov 05, 2010: Rodman Announces Panel Discussion On Wound Care 109
15.6 Product News 110
15.6.1 Sep 20, 2012: Pilot Study In Patients With Head And Neck Cancer Finds That Derma Sciences’ Medihoney Reduces Hospital Stays In UK 110
15.6.2 Sep 06, 2012: Derma Sciences Launches Medihoney HCS In US 111
15.6.3 Jul 10, 2012: Derma Sciences Receives CE Mark For Medihoney HCS 111
15.6.4 Aug 08, 2011: Derma Sciences Achieves Key MEDIHONEY Sales Milestone 112
15.6.5 Aug 01, 2011: Derma Sciences Receives FDA Clearance For MEDIHONEY Hydrogel 112
15.6.6 Feb 28, 2011: Derma Sciences Receives FDA Clearance For MEDIHONEY Gel 113
15.6.7 Jul 09, 2010: Derma Sciences Submits 510(k) Application For MEDIHONEY Gel 113
15.6.8 Jun 22, 2010: Derma Sciences Announces Issuance Of Second US Patent To MEDIHONEY Alginate Dressing 113
15.6.9 Jun 07, 2010: Derma Sciences Receives CE Mark For ALGICELL Ag Wound Dressings 114
15.6.10 May 04, 2010: Derma Sciences Launches XTRASORB Foam Wound Dressing 114
15.6.11 Apr 20, 2010: Two Posters Featuring Derma Sciences’ MEDIHONEY Wins Top Honors At American Professional Wound Care Association’s 10th Annual Conference 115
15.6.12 Apr 06, 2010: Derma Sciences To Feature MEDIHONEY At American Professional Wound Care Association’s Annual Conference 115
15.6.13 Oct 21, 2009: Derma Sciences To Present Clinical Case Series Of MEDIHONEY At Upcoming Clinical Symposium On Advances In Skin And Wound Care 116
15.6.14 Feb 13, 2009: In Case Studies MEDIHONEY Dressings Proves To Be Effective For Non-Healing Venous Leg Ulcers 116
15.6.15 Oct 21, 2008: Derma Sciences Announces Commercial Launch Of XTRASORB 117
15.6.16 Sep 15, 2008: Derma Sciences Inc’s MEDIHONEY Proven To Speed Healing In Stalled Leg Ulcers 117
15.6.17 Sep 03, 2008: Derma Sciences Announces Launch Plan For MOBILITY1 Intermittent Compression Therapy Device 117
15.6.18 Jul 28, 2008: Derma Sciences Signs Innovative Technology Agreement With Novation For MEDIHONEY Wound & Burn Dressings 118
15.6.19 Jun 26, 2008: Derma Sciences Launches Honeycolloid 118
15.6.20 Jun 26, 2008: Derma Sciences Launches New MEDIHONEY Formulations : Active Leptospermum Honey 119
15.6.21 Jun 24, 2008: Derma Sciences Receives FDA Clearance To Sell MEDIHONEY Over The Counter 119
15.6.22 Jun 18, 2008: Derma Sciences MEDIHONEY Helps To Save Patient’s Limb 120
15.6.23 Apr 23, 2008: Derma Sciences Announces Agreement With MedAssets For MEDIHONEY Wound & Burn Dressings 120
15.6.24 Apr 08, 2008: New Study Shows The Use Of MEDIHONEY Wound & Burn Dressing Is Associated With Reduction In Wound Size 120
15.6.25 Mar 25, 2008: Derma Sciences’ MEDIHONEY Profiled In Several Television News Health Reports 121
15.6.26 Mar 20, 2008: Derma Sciences Announces Clinical Poster On Use Of MEDIHONEY Wound & Burn Dressings Wins First Place Award At APWCA 122
15.6.27 Mar 06, 2008: Derma Sciences Announces Numerous Clinical Presentations On MEDIHONEY Wound & Burn Dressings At Upcoming SAWC Conference 123
15.6.28 Nov 15, 2007: Derma Sciences Receives Second FDA 510K Clearance And Adds To Their MEDIHONEY Wound & Burn Dressings With Active Leptospermum Honey 123
15.7 Product Approvals 124
15.7.1 Aug 01, 2011: Derma Sciences Receives FDA Clearance For MEDIHONEY Hydrogel 124
15.7.2 Jun 07, 2010: Derma Sciences Receives CE Mark For ALGICELL Ag Wound Dressings 124
15.7.3 Jun 24, 2008: Derma Sciences Receives FDA Clearance To Sell MEDIHONEY Over The Counter 125
15.7.4 Nov 15, 2007: Derma Sciences Receives Second FDA 510K Clearance And Adds To Their MEDIHONEY Wound & Burn Dressings With Active Leptospermum Honey 125
15.8 Clinical Trials 126
15.8.1 Feb 13, 2009: In Case Studies MEDIHONEY Dressings Proves To Be Effective For Non-Healing Venous Leg Ulcers 126
15.8.2 Sep 15, 2008: Derma Sciences Inc’s MEDIHONEY Proven To Speed Healing In Stalled Leg Ulcers 126
15.8.3 Jun 18, 2008: Derma Sciences MEDIHONEY Helps To Save Patient’s Limb 126
15.8.4 Apr 08, 2008: New Study Shows The Use Of MEDIHONEY Wound & Burn Dressing Is Associated With Reduction In Wound Size 127
15.9 Other Significant Developments 128
15.9.1 Sep 02, 2010: Derma Sciences XTRASORB Product Line Receive Federal Reimbursement Codes 128
15.9.2 Feb 23, 2010: Derma Sciences Extends Contract Term With Quick-Med 128
15.9.3 May 06, 2009: Derma Sciences Signs Private Label Contract To Supply Label Adhesive Bandages 129
15.9.4 Jul 28, 2008: Derma Sciences Signs Two Year Distribution Agreement With Novation For MEDIHONEY Wound & Burn Dressings 130
15.9.5 Apr 23, 2008: Derma Sciences Signs Three Year Supply Agreement With MedAssets For MEDIHONEY Wound & Burn Dressings 130
15.9.6 Jan 18, 2008: Derma Sciences Increases Direct Sales Force For Advanced Wound Care 131
15.9.7 Apr 02, 2007: QMTI Signs License Agreement With DSI 131
16 Appendix 132
16.1 Research Methodology 133
16.2 Secondary Research 133
16.3 Primary Research 133
16.4 Models 134
16.5 Forecasts 134
16.6 Expert Panels 134
16.7 GlobalData Consulting 134
16.8 Currency Conversion 135
16.9 Contact Us 136
16.10 Disclaimer 136
【レポート販売概要】
■ タイトル:Derma Sciences, Inc.:市場シェア分析■ 英文:Derma Sciences, Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160490
■ 調査対象地域:グローバル
- ルーマニアの通信、IPネットワーク、デジタルメディア市場RomTelecom prepares for next attempt at privatisation as well as a rebrandRomania’s fixed-line telecoms market is evolving under the weight of competition and technological change. Implementation of EU Directives has opened the telecoms market to competition and introduced a regulatory framework designed to foster effective competition. Alternative operators have launched competing services in the …
- 眼科機器の世界市場:光干渉断層撮影(OCT)、眼底カメラ、検眼鏡、眼圧計、フォロプター、細隙灯、眼内レンズ(IOL)、超音波水晶体乳化吸引術、エキシマー・レーザー、フェムト秒レーザ、コンタクトレンズThe global ophthalmology devices market is estimated to reach USD 58.05 Billion by 2021, at a CAGR of 3.7% during the forecast period. This growth in aging population and related increase in the eye diseases is a key factor driving the global ophthalmology devices market. The lower adoption of phacoemulsification devices and premium intra ocular lenses (IOLs) in the emerging regions represents a h …
- 世界の光ファイバテスト装置市場2015The Global Fiber Optic Test Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Fiber Optic Test Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Fiber Optic Test Equipment market analysis is provided for the international markets …
- 石油・ガス産業向けプロセス安全システムの世界市場About Process Safety Systems Safety systems are designed to protect personnel and the environment during plant operations if/when a process goes beyond the defined control margins. There are various types of safety systems including fire and gas safety systems and burner gas management. These safety systems are used across various process industries such as Oil and Gas, Chemical, Refining, Power, …
- 相互接続素子・受動素子の世界市場予測(~2022):抵抗器、コンデンサ、誘導子、トランス、ダイオード、PCB、コネクタ、スイッチ、リレー、アダプター、ターミナル、スプライス、ソケットAccording to the MarketsandMarkets forecast, the interconnects and passive components market is expected to be valued at USD 187.55 Billion by 2022, growing at a CAGR of 4.41% between 2017 and 2022. The growth of the interconnects and passive components market is attributed to advancements in the industrial M2M communication technology and rising industrial automations, increasing demand for minia …
- IP Multimedia Subsystem (IMS): The Market for Applications and Services 2011-2016This report presents a qualitative and quantitative analysis of the role of IP Multimedia Subsystem (IMS) in implementing rich multimedia applications. This report evaluates a variety of IMS market opportunities and places emphasis on a few key applications including: * Video Calls * Unified Messaging * Push-to-Talk * Wireless Wireline Convergence * Online Gaming * Video-on-Demand The above applic …
- ジェネレーティブデザインの世界市場予測(~2023年)Rising need for advanced product design software to drive product innovation is driving the growth of the marketThe global generative design market to grow from USD 111 million in 2018 to USD 275 million by 2023, at a CAGR of 19.9% during the forecast period. The generative design market is growing rapidly with the rising need for advanced product design software, growing demand for environment-fr …
- 農業用可変作業技術(VRT)の世界市場2018-2022About Farm Variable Rate Technologies (VRT) Farm VRT enable various applications of inputs such as fertilizers, chemicals, pesticides, and irrigation across different fields at various rates as per the requirement. Technavio’s analysts forecast the Global Farm Variable Rate Technologies (VRT) Market to grow at a CAGR of 11.42% during the period 2018-2022. Covered in this report The report covers t …
- 寒冷式疼痛治療の世界市場予測(~2021年):OTC医薬品、医療機器、処方薬Cold pain therapy is among the most commonly adopted methods for the temporary management of pain and inflammation, sprains, strains, bumps, bruises, and arthritis. Pharmaceuticals used for cold pain therapy have menthol as their active ingredient (with menthol content of 1% and above), whereas medical devices have ice or cold water as their key component. Menthol in topical analgesics acts as a c …
- Petrominerales Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Petrominerales Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Petrominerales Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- NK細胞リンパ腫:グローバル臨床試験レビュー(2014年上半期)Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the Natural Killer Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Natural Killer Cell Lymphomas. It includes an overv …
- トレーシール機の世界市場2018-202299 pages, November 2018 About this market Tray sealing machinery manufacturers are investing heavily in research and development to upgrade their products with new features. For instance, ProMach introduced several new tray sealing solutions under the brand name Ossid in 2016. The vacuum skin pack/modified atmosphere packaging feature of its OTS-10VMAP tabletop tray sealer ensures a longer shelf l …
- 建設機械レンタルの世界市場2015-2019The equipment rental market is generally operated by third party suppliers or equipment manufacturers that offer used equipment on rent to the construction companies based on the project duration. The rapid growth of the construction industry is a significant factor that spurs the prospects for growth in this market during the forecast period. The recent increase in infrastructure development is o …
- 産業用伝送器(発信器)の世界市場:フロー伝送器、レベル伝送器、圧力伝送器、温度伝送器About Industrial Transmitters Industrial transmitters are widely used in all industrial applications for measuring, monitoring, testing, and automation. The value chain extends from the detection of process parameters in process industries to the analysis of specifications and characteristics of the final product. IoT has introduced new growth opportunities in the global industrial transmitters ma …
- 腸炎(Enteritis):世界の治験レビュー(2015年上半期版)Enteritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Enteritis Global Clinical Trials Review, H1, 2015" provides data on the Enteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Enteritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …